Abstract
Lymphedema is a common morbid after cancer treatment. The disease characterizes with progressive inflammatory process that result in irreversible fibrosis. Its chronology and progressive disease character often impacts the quality of life of cancer survivors. The pathophysiology of lymphedema remains unclear and the disease remains non-curable. In this article, we reviewed available studies of lymphedema and concluded possible treatment strategies for lymphedema. J. Surg. Oncol. 2017;115:96–98.
| Original language | English |
|---|---|
| Pages (from-to) | 96-98 |
| Number of pages | 3 |
| Journal | Journal of Surgical Oncology |
| Volume | 115 |
| Issue number | 1 |
| DOIs | |
| State | Published - 01 01 2017 |
Bibliographical note
Publisher Copyright:© 2016 Wiley Periodicals, Inc.
Keywords
- T-cell
- inflammation
- lymphedema
